Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:8206281.
doi: 10.1155/2017/8206281. Epub 2017 Feb 2.

The Protective Effect of Chrysanthemum indicum Extract against Ankylosing Spondylitis in Mouse Models

Affiliations

The Protective Effect of Chrysanthemum indicum Extract against Ankylosing Spondylitis in Mouse Models

Mei Dong et al. Biomed Res Int. 2017.

Erratum in

Abstract

In traditional Chinese and Korean homeopathic medicine, Chrysanthemum indicum Linné (Asteraceae) is a time-honored herb, prescribed for the resolution of symptoms associated with inflammatory and hypertensive conditions as well as those affecting the lungs and its associated structures. The goal of this work is to investigate the defensive role of Chrysanthemum indicum extract in fighting ankylosing spondylitis (AS) using mouse models, through which the manifestation and extent of the disease progression were measured with quantitative analysis of the intervertebral joints. Markers of inflammation as well as oxidative stress were also analysed. Western blot was used to quantify the levels of Nuclear Factor-κB (NF-κB) p65, Dickkopf-1 (DKK-1), and sclerostin (SOST). Consequently, the findings of this experiment demonstrated that AS in mice that were given Chrysanthemum indicum extract had lower level of TNF-α, IL-1β, and IL-6 (P < 0.05) and increased level of catalase (CAT), glutathione peroxidase (GSH-PX), and superoxide dismutase (SOD) (P < 0.05). The results also revealed that Chrysanthemum indicum supplemented with diet contributed to a decrease in Nuclear Factor-κB (NF-κB) p65 protein expression (P < 0.05) and higher levels of DKK-1 and SOST proteins (P < 0.05). Therefore, we concluded that the beneficial role of Chrysanthemum indicum in AS is manifested through downregulating oxidative stress, inhibiting inflammatory mediators and NF-κB, and increasing DKK-1 and SOST levels.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Impact of dietary Chrysanthemum indicum extract on (a) peripheral disease progression and (b) average joints score. Different superscripts shown on the data indicate being statistically different from each other (P < 0.05; n = 10).
Figure 2
Figure 2
The effect of Chrysanthemum indicum extract on (a) TNF-α, (b) IL-1β, and (c) IL-6 in mice. Different superscripts shown on the data indicate being statistically different from each other (P < 0.05; n = 10).
Figure 3
Figure 3
Effect of Chrysanthemum indicum extract on MDA and antioxidative enzymes. Dietary Chrysanthemum indicum extract affects concentrations of (a) MDA, (b) SOD, (c) CAT, and (d) GSH-PX. Different superscripts shown on the data indicate being statistically different from each other (P < 0.05; n = 10).
Figure 4
Figure 4
The effect of Chrysanthemum indicum extract on NF-κB p65 protein expression in AS mouse model. Different superscripts shown on the data indicate being statistically different from each other (P < 0.05; n = 10).
Figure 5
Figure 5
Effects of Chrysanthemum indicum extract on (a) SOST and (b) DKK-1 protein expression in mouse models. Different superscripts shown on the data indicate being statistically different from each other (P < 0.05; n = 10).

Similar articles

Cited by

References

    1. Liu Y.-F., Dong H., Tu S.-H., Zheng C.-H., Liu P.-L., Hu Y.-H. Etanercept in the treatment of ankylosing spondylitis: a systematic review and meta-analysis. Experimental and Therapeutic Medicine. 2014;8(5):1585–1592. doi: 10.3892/etm.2014.1974. - DOI - PMC - PubMed
    1. Colbert R. A., Tran T. M., Layh-Schmitt G. HLA-B27 misfolding and ankylosing spondylitis. Molecular Immunology. 2014;57(1):44–51. doi: 10.1016/j.molimm.2013.07.013. - DOI - PMC - PubMed
    1. Dean L. E., Jones G. T., Macdonald A. G., Downham C., Sturrock R. D., Macfarlane G. J. Global prevalence of ankylosing spondylitis. Rheumatology. 2014;53(4):650–657. doi: 10.1093/rheumatology/ket387. - DOI - PubMed
    1. Chou C.-T., Huo A.-P., Chang H.-N., Tsai C.-Y., Chen W.-S., Wang H.-P. Cytokine production from peripheral blood mononuclear cells in patients with ankylosing spondylitis and their first-degree relatives. Archives of Medical Research. 2007;38(2):190–195. doi: 10.1016/j.arcmed.2006.09.008. - DOI - PubMed
    1. van der Heijde D., Landewé R., Baraliakos X., et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis & Rheumatism. 2008;58(10):3063–3070. doi: 10.1002/art.23901. - DOI - PubMed

MeSH terms